345 related articles for article (PubMed ID: 33218939)
21. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
[TBL] [Abstract][Full Text] [Related]
22. A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma.
Liu JS; Huang Y; Yang X; Feng JF
Am J Cancer Res; 2015; 5(7):2180-9. PubMed ID: 26328248
[TBL] [Abstract][Full Text] [Related]
23. Predicting Severe Radiation Esophagitis in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: Construction and Validation of a Model Based in the Clinical and Dosimetric Parameters as Well as Inflammatory Indexes.
Yu Y; Zheng H; Liu L; Li H; Zheng Q; Wang Z; Wu Y; Li J
Front Oncol; 2021; 11():687035. PubMed ID: 34249736
[TBL] [Abstract][Full Text] [Related]
24. Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma.
Kijima T; Arigami T; Uchikado Y; Uenosono Y; Kita Y; Owaki T; Mori S; Kurahara H; Kijima Y; Okumura H; Maemura K; Ishigami S; Natsugoe S
Cancer Sci; 2017 Feb; 108(2):193-199. PubMed ID: 27889946
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
26. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer.
Hirahara T; Arigami T; Yanagita S; Matsushita D; Uchikado Y; Kita Y; Mori S; Sasaki K; Omoto I; Kurahara H; Maemura K; Okubo K; Uenosono Y; Ishigami S; Natsugoe S
BMC Cancer; 2019 Jul; 19(1):672. PubMed ID: 31286873
[TBL] [Abstract][Full Text] [Related]
27. The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients.
Wang H; Huang Z; Xu B; Zhang J; He P; Gao F; Zhang R; Huang X; Shan M
Clin Transl Oncol; 2024 Jun; 26(6):1467-1479. PubMed ID: 38190034
[TBL] [Abstract][Full Text] [Related]
28. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
29. Chemoradiation-induced changes in systemic inflammatory markers and their prognostic significance in oesophageal squamous cell carcinoma.
Khin NS; Tan SH; Wang ML; Siow TR; Lim FL; Wang FQ; Ng MC; Lam JY; Yip C
Br J Radiol; 2021 Jun; 94(1122):20200314. PubMed ID: 33861156
[TBL] [Abstract][Full Text] [Related]
30. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.
He YF; Luo HQ; Wang W; Chen J; Yao YW; Yan Y; Wu SS; Hu XX; Ke LH; Niu JY; Li HM; Ji CS; Hu B
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26947428
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory biomarkers as predictors of immune activation to different irradiated sites and short-term efficacy in advanced squamous cell esophageal carcinoma received radioimmunotherapy.
Li M; Cai G; Gao Z; Meng X; Han X
Front Oncol; 2023; 13():1117648. PubMed ID: 37234974
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
[TBL] [Abstract][Full Text] [Related]
33. The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study.
Huang C; Wang M; Chen L; Wang H; Huang D; Shi J; Zhang W; Tian Y; Zhu Y
BMC Cancer; 2023 Jun; 23(1):505. PubMed ID: 37270496
[TBL] [Abstract][Full Text] [Related]
34. The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy.
Xu Z; Ke H; Zheng B; Lin C; Zhang Y; Wang L; Lin Y; Ye Y; Cai L; You M; Chen J; Xu Y
Cancer Control; 2023; 30():10732748231185025. PubMed ID: 37339928
[TBL] [Abstract][Full Text] [Related]
35. Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation.
Chen Y; Yang Y; Zhang XY; Fan QS; Li X; Xin YJ; Cao XJ; Wang YN; Zhou X
Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1551-1560. PubMed ID: 34036405
[TBL] [Abstract][Full Text] [Related]
36. Effect of dynamic platelet-to-lymphocyte ratio on the prognosis of patients with esophageal squamous cell carcinoma receiving chemoradiotherapy.
He D; Du S; He S; Song H; Pu B; Zhang G; Yang C
Medicine (Baltimore); 2023 Dec; 102(49):e36554. PubMed ID: 38065887
[TBL] [Abstract][Full Text] [Related]
37. The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma.
Cong L; Hu L
Int Immunopharmacol; 2017 May; 46():75-79. PubMed ID: 28268208
[TBL] [Abstract][Full Text] [Related]
38. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of systemic inflammatory response markers in patients with superficial esophageal squamous cell carcinomas.
Chen CJ; Lee CT; Tsai YN; Tseng CM; Chen TH; Hsu MH; Wang CC; Wang WL
Sci Rep; 2022 Oct; 12(1):18241. PubMed ID: 36309551
[TBL] [Abstract][Full Text] [Related]
40. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]